The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening

被引:10
|
作者
Bhojani, Naeem [1 ,2 ]
Perrotte, Paul [2 ]
Jeldres, Claudio [1 ,2 ]
Suardi, Nazareno [1 ,3 ]
Hutterer, Georg [1 ,4 ]
Shariat, Shahrokh F. [5 ]
Karakiewicz, Pierre I. [1 ,2 ]
机构
[1] Univ Montreal, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
[2] Univ Montreal, Ctr Hlth, CHUM, Dept Urol, Montreal, PQ, Canada
[3] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy
[4] Graz Med Univ, Dept Urol, Graz, Austria
[5] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
来源
JOURNAL OF SEXUAL MEDICINE | 2008年 / 5卷 / 03期
关键词
comorbidities; quality of life; sexual function; socioeconomic Status; urinary function;
D O I
10.1111/j.1743-6109.2007.00722.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Comorbidities and socioeconomic status (SES) represent known confounders of baseline health-related quality of life. Aim. To assess the effect of comorbidities and of SES variables on urinary function (UF) and sexual function (SF) and on associated bother items. Methods. A cohort of 1,162 men without an established diagnosis of prostate cancer (PCa) completed questionnaires addressing SES characteristics, the lifetime prevalence of 12 comorbid conditions, SF and UF as well as their associated bother. Main Outcome Measures. Crude and adjusted logistic regression models tested the association between the predictors, SES and comorbidity, and four separate outcomes, namely SF and UF and their associated bother. Results. Of all men, aged 40-79 years, 172 (14.8%) reported poor or very poor ability to have an erection, and for 165 (14.2%), erectile function (EF) was a big or moderate problem. Daily or weekly urinary incontinence was reported by 98 (8.4%) men, and for 94 (8.1%) men, UF was a big or moderate problem. One or more comorbidities were present in 437 (37.6%) men. In age- and SES-adjusted analyses, major depression and diabetes had the most detrimental effect on EF (5.8 [P < 0.001] and 4.8 [P < 0.001], respectively) and on sexual bother (4.3 [P < 0.001] and 7.2 [P < 0.001], respectively). Stroke (4.7 [P = 0.004]) and drug problems (4.8 [P = 0.002]) had the most detrimental effect on urinary incontinence. Alcoholism and alcohol-related problems (3.1 [P = 0.004]) had the most detrimental effect on the urinary bother scale. Finally, SES only affected urinary incontinence, which was poorer in men who lived with a spouse or partner (2.1 [P = 0.03]). Conclusion. Select comorbidities have very strong effects on UF and EF. Conversely, for most SES variables, the effect was weak and insignificant. In consequence, when patients are assessed for definitive PCa therapy, comorbidities require an adjustment, whereas SES assessment may potentially be omitted, especially if questionnaire brevity is a consideration.
引用
收藏
页码:668 / 676
页数:9
相关论文
共 50 条
  • [41] URINARY PCA 3 AS A PREDICTOR FOR PROSTATE CANCER IN A COHORT OF 1928 MEN UNDERGOING INITIAL PROSTATE BIOPSY
    Chevli, K. Kent
    Duff, Michael
    Yu, Changhong
    Capuder, Brian
    Elshafei, Ahmed
    Malczewski, Stephanie
    Kattan, Michael
    Jones, J. Stephen
    JOURNAL OF UROLOGY, 2012, 187 (04): : E489 - E489
  • [42] THE INFLUENCE OF TESTOSTERONE SUPPRESSION AND RECOVERY ON SEXUAL FUNCTION IN MEN WITH PROSTATE CANCER: OBSERVATIONS FROM A PROSPECTIVE STUDY IN MEN UNDERGOING INTERMITTENT ANDROGEN SUPPRESSION
    Evan Ng
    Woo, Henry
    Turner, Sandra
    Leong, Eugene
    Jackson, Melanie
    Spry, Nigel
    JOURNAL OF UROLOGY, 2012, 187 (04): : E603 - E604
  • [43] The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: observations from a prospective study in men undergoing intermittent androgen suppression
    Ng, E.
    Woo, H. H.
    Turner, S.
    Leong, E.
    Jackson, M.
    Spry, N.
    BJU INTERNATIONAL, 2012, 109 : 15 - 16
  • [44] The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression
    Ng, Evan
    Woo, Henry H.
    Turner, Sandra
    Leong, Eugene
    Jackson, Melanie
    Spry, Nigel
    JOURNAL OF UROLOGY, 2012, 187 (06): : 2162 - 2166
  • [45] SEXUAL FUNCTIONING IN MEN WITH PROSTATE CANCER
    Quinta Gomes, Ana Luisa
    Janssen, Erick
    Adaikan, Ganesan
    Nobre, Pedro
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (05): : E339 - E339
  • [46] Comorbidities, Treatment and Ensuing Survival in Men with Prostate Cancer
    Chamie, Karim
    Daskivich, Timothy J.
    Kwan, Lorna
    Labo, Jessica
    Dash, Atreya
    Greenfield, Sheldon
    Litwin, Mark S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 (05) : 492 - 499
  • [47] Comorbidities, Treatment and Ensuing Survival in Men with Prostate Cancer
    Karim Chamie
    Timothy J. Daskivich
    Lorna Kwan
    Jessica Labo
    Atreya Dash
    Sheldon Greenfield
    Mark S. Litwin
    Journal of General Internal Medicine, 2012, 27 : 492 - 499
  • [48] Patient utilities for urinary, sexual, and bowel dysfunction in men at risk for prostate cancer.
    Saigal, CS
    Nease, RF
    Kaminski, ALR
    Litwin, MS
    JOURNAL OF UROLOGY, 1998, 159 (05): : 259 - 259
  • [49] PATIENT REPORTED SEXUAL AND URINARY FUNCTIONAL OUTCOMES IN MEN WITH INTERMEDIATE RISK PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY: ANALYSIS OF THE MUSIC REGISTRY
    Paudel, Roshan
    Cochrane, John
    Qi, Ji
    Cher, Michael
    Sarle, Richard
    Peabody, James
    Jafri, S. Mohammad
    Lane, Brian
    Semerjian, Alice
    George, Arvin
    Ginsburg, Kevin
    JOURNAL OF UROLOGY, 2022, 207 (05): : E986 - E986
  • [50] The relative effect of mammographic screening on breast cancer mortality by socioeconomic status
    Ripping, Theodora M.
    van der Waal, Danielle
    Verbeek, Andre L. M.
    Broeders, Mireille J. M.
    MEDICINE, 2016, 95 (31)